Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedMay 10, 2017Rabeprazole Sodium Delayed Release TabletsFailed Dissolution SpecificationsAmneal Pharmaceuticals LLC · D-0693-2017Class IIITerminatedMay 10, 2017Aripiprazole TabletsSuperpotent Drug; out of specification results for assay (manufacturer)The Harvard Drug Group · D-0692-2017Class IOngoingMay 10, 2017EpiPen Jr. 2-PakDefective Delivery System; reports of the device failing to activate which could result in a patient not receiving medicationMeridian Medical Technologies a Pfizer Company · D-0691-2017Class IOngoingMay 10, 2017EpiPen 2-PakDefective Delivery System; reports of the device failing to activate which could result in a patient not receiving medicationMeridian Medical Technologies a Pfizer Company · D-0690-2017Class IITerminatedMay 10, 2017Fluconazole TabletsFailed Dissolution SpecificationsThe Harvard Drug Group · D-0689-2017Class IITerminatedMay 10, 2017Fluconazole TabletsFailed Dissolution SpecificationsThe Harvard Drug Group · D-0688-2017Class IITerminatedMay 3, 2017Phenylephrine 2.5%Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.Isomeric Pharmacy Solution, LLC · D-0687-2017Class IITerminatedMay 3, 2017Testosterone Cypionate 200 mg/mLLack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.Isomeric Pharmacy Solution, LLC · D-0686-2017Class IITerminatedMay 3, 2017Cyanocobalamin 1 mg/mL/ Methionine 25 mg/mL/ Inositol 50 mg/mL/ Choline 50 mg/mLLack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.Isomeric Pharmacy Solution, LLC · D-0685-2017Class IITerminatedMay 3, 2017Triamcinolone Diacetate 40 mg/mLLack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.Isomeric Pharmacy Solution, LLC · D-0684-2017Class IITerminatedMay 3, 2017Triamcinolone Acetonide 40 mg/mLLack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.Isomeric Pharmacy Solution, LLC · D-0683-2017Class IITerminatedMay 3, 2017Methylprednisolone Acetate 80 mg/mLLack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.Isomeric Pharmacy Solution, LLC · D-0682-2017Class IITerminatedMay 3, 2017Methylprednisolone Acetate 40 mg/mLLack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.Isomeric Pharmacy Solution, LLC · D-0681-2017Class IIITerminatedMay 3, 2017Donepezil HCl tabletsSupotent: Out of Specification result for assay test during routine stability testing.Mckesson Packaging Services · D-0680-2017Class IIITerminatedMay 3, 2017Pilocarpine Hydrochloride Ophthalmic Solution 4%Failed Impurities/Degradation Specifications.Novartis Pharmaceuticals Corp. · D-0679-2017Class IIITerminatedMay 3, 2017Isopto CarpineFailed Impurities/Degradation Specifications.Novartis Pharmaceuticals Corp. · D-0678-2017Class IITerminatedMay 3, 2017hCG Body ShaperMarketed without an Approved NDA/ANDA; FDA analysis has found the product to be tainted with human chorionic gonadotropin, rendering it an unapproved drugGary Wood · D-0677-2017Class IITerminatedApr 26, 2017Nystatin and Triamcinolone Acetonide CreamFailed Content Uniformity Specifications; out-of-specification (OOS) results 18-month stabilityTaro Pharmaceuticals U.S.A., Inc. · D-0676-2017Class IIITerminatedApr 26, 2017Dye Free Allergy Softgel Gelatin CapsuleSubpotentInnovaGel · D-0675-2017Class IIITerminatedApr 26, 2017Diphenhydramine HCl 25 mgSubpotentInnovaGel · D-0674-2017Class IIITerminatedApr 26, 2017CLENZIderm M.D. Acne Treatment SystemDiscoloration.Valeant Pharmaceuticals North America LLC · D-0673-2017Class IIITerminatedApr 26, 2017CLENZIderm M.D. Pore Therapy Salicylic Acid 2% Acne Treatment 5 fl. ozDiscoloration.Valeant Pharmaceuticals North America LLC · D-0672-2017Class IIITerminatedApr 19, 2017BuPROPion Hydrochloride Extended-release TabletsFailed Impurities/Degradation Specifications: high out of specification results for one of the known degradation products, m-chlorobenzoic acid.Jubilant Cadista Pharmaceuticals, Inc. · D-0671-2017Class IIITerminatedApr 19, 2017BuPROPion Hydrochloride Extended-release TabletsFailed Impurities/Degradation Specifications: high out of specification results for one of the known degradation products, m-chlorobenzoic acid.Jubilant Cadista Pharmaceuticals, Inc. · D-0670-2017Class IIITerminatedApr 19, 2017BuPROPion Hydrochloride Extended-release TabletsFailed Impurities/Degradation Specifications: high out of specification results for one of the known degradation products, m-chlorobenzoic acid.Jubilant Cadista Pharmaceuticals, Inc. · D-0669-2017Class IITerminatedApr 19, 2017hydrALAZINE HYDROCHLORIDE INJECTIONTemperature Abuse: Certain pieces of these lots distributed by McKesson Medical Surgical Inc. were inadvertently stored refrigerated rather than the labeled room...Mckesson Medical Surgical · D-0668-2017Class IIITerminatedApr 19, 2017LumiganFailed Impurities/Degradation SpecificationsAllergan Sales, LLC · D-0667-2017Class IITerminatedApr 19, 2017ESTRADIOLcGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspectionMedisca, Inc. · D-0666-2017Class IITerminatedApr 19, 2017ESTRADIOLcGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspectionMedisca, Inc. · D-0665-2017Class IITerminatedApr 19, 2017ESTRONE, USP BulkcGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspectionMedisca, Inc. · D-0664-2017Class IITerminatedApr 19, 2017ESTRIOL, USPcGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspectionMedisca, Inc. · D-0663-2017Class IIOngoingApr 19, 2017Double Hyaluronic 1000Microbial Contamination of Non-Sterile Products: odor complaint of product due to microbial contamination.Signature Club A Ltd · D-0662-2017Class IITerminatedApr 19, 2017LATANOPROST OPHTHALMIC SOLUTIONLack of assurance of sterility: product was found to be empty, under-filled, or leaking.Akorn, Inc. · D-0661-2017Class IITerminatedApr 19, 2017Levonorgestrel Non-MicronizedcGMP Deviations; lack of quality assurance.Qinhuangdao Zizhu Pharmaceutical, Co. · D-0660-2017Class IITerminatedApr 19, 2017Ethinyl Estradiol MicronizedcGMP Deviations; lack of quality assurance.Qinhuangdao Zizhu Pharmaceutical, Co. · D-0659-2017Class IITerminatedApr 19, 2017Testosterone MicronizedcGMP Deviations; lack of quality assurance.Qinhuangdao Zizhu Pharmaceutical, Co. · D-0658-2017Class IITerminatedApr 19, 2017Estrone MicronizedcGMP Deviations; lack of quality assurance.Qinhuangdao Zizhu Pharmaceutical, Co. · D-0657-2017Class IITerminatedApr 19, 2017Estriol MicronizedcGMP Deviations; lack of quality assurance.Qinhuangdao Zizhu Pharmaceutical, Co. · D-0656-2017Class IITerminatedApr 19, 2017Estradiol Non-MicronizedcGMP Deviations; lack of quality assurance.Qinhuangdao Zizhu Pharmaceutical, Co. · D-0655-2017Class IITerminatedApr 19, 2017Estradiol Micronized BulkcGMP Deviations; lack of quality assurance.Qinhuangdao Zizhu Pharmaceutical, Co. · D-0654-2017